A bit more to explain my last post and thoughts........
AIPAC PH2 data due H1/2019.....
EMA stated interest in priority status reliant on aipac results...
Chinese Manufacterer WUXI, first Chinese drug maker accepted by EMA...
WUXI have justed expanded their production facilities....
Marc Voight has said on a number of occasions the strong partnership
Immutep have with WUXI.....
I'm thinking there could be a favourable payment schedule negotiated
between Immutep and WUXI for production if AIPAC gets the green light...
As I said, it's just me, but I've been thinking about this possibility for
quite a while......Anyway, don't take my word for nothin, I could be
way wrong...
immuno-oncology weekly, page-23
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
